Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince you to switch. Java continues its fast and feature-packed release schedule, ...
James' experience in writing is rooted in his academic achievements. Maintaining high grades that granted him the status of being on the dean's list, his classes revolved around creative fictional ...
Abstract: Semi-Supervised Few-Shot Learning (SSFSL) aims to address the data scarcity in few-shot learning by leveraging both a few labeled support data and abundant unlabeled data. In SSFSL, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results